The overarching framework of translation and integration into healthcare

A case for the LAL model

Jonathan A. Lal, Servaas A. Morré, Angela Brand

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Recently, there has been a substantial increase in relevant genome-based technologies into market. Compared with its utilization in healthcare systems, we notice a huge gap. In order to address this bottleneck, we previously developed the Learning-Adapting-Leveling (LAL) model. Aim: In this article, we aim to demonstrate the overarching reach of the model for translation to market and implementation into healthcare systems moving towards personalized healthcare. Methods: We use qualitative logical reasoning with the LAL model as a reference. Results: We found that technology transfer, health needs assessment, health technology assessment and health impact assessment are justified for their inclusion. In addition, the public health wheel is justified as a good reference frame along with value of information. Conclusion: We conclude that as the LAL model covers all dimensions and tools for translation and implementation in a defined method; it can therefore be considered as the overarching framework for translation and implementation into healthcare.

Original languageEnglish
Pages (from-to)41-62
Number of pages22
JournalPersonalized Medicine
Volume11
Issue number1
DOIs
Publication statusPublished - 01-2014

Fingerprint

Learning
Delivery of Health Care
Health Impact Assessment
Technology Transfer
Biomedical Technology Assessment
Needs Assessment
Public Health
Genome
Technology
Health

All Science Journal Classification (ASJC) codes

  • Medicine(all)
  • Molecular Medicine
  • Pharmacology

Cite this

@article{6679dc73c8c646a1be43c300cef91a82,
title = "The overarching framework of translation and integration into healthcare: A case for the LAL model",
abstract = "Background: Recently, there has been a substantial increase in relevant genome-based technologies into market. Compared with its utilization in healthcare systems, we notice a huge gap. In order to address this bottleneck, we previously developed the Learning-Adapting-Leveling (LAL) model. Aim: In this article, we aim to demonstrate the overarching reach of the model for translation to market and implementation into healthcare systems moving towards personalized healthcare. Methods: We use qualitative logical reasoning with the LAL model as a reference. Results: We found that technology transfer, health needs assessment, health technology assessment and health impact assessment are justified for their inclusion. In addition, the public health wheel is justified as a good reference frame along with value of information. Conclusion: We conclude that as the LAL model covers all dimensions and tools for translation and implementation in a defined method; it can therefore be considered as the overarching framework for translation and implementation into healthcare.",
author = "Lal, {Jonathan A.} and Morr{\'e}, {Servaas A.} and Angela Brand",
year = "2014",
month = "1",
doi = "10.2217/pme.13.97",
language = "English",
volume = "11",
pages = "41--62",
journal = "Personalized Medicine",
issn = "1741-0541",
publisher = "Future Medicine Ltd.",
number = "1",

}

The overarching framework of translation and integration into healthcare : A case for the LAL model. / Lal, Jonathan A.; Morré, Servaas A.; Brand, Angela.

In: Personalized Medicine, Vol. 11, No. 1, 01.2014, p. 41-62.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The overarching framework of translation and integration into healthcare

T2 - A case for the LAL model

AU - Lal, Jonathan A.

AU - Morré, Servaas A.

AU - Brand, Angela

PY - 2014/1

Y1 - 2014/1

N2 - Background: Recently, there has been a substantial increase in relevant genome-based technologies into market. Compared with its utilization in healthcare systems, we notice a huge gap. In order to address this bottleneck, we previously developed the Learning-Adapting-Leveling (LAL) model. Aim: In this article, we aim to demonstrate the overarching reach of the model for translation to market and implementation into healthcare systems moving towards personalized healthcare. Methods: We use qualitative logical reasoning with the LAL model as a reference. Results: We found that technology transfer, health needs assessment, health technology assessment and health impact assessment are justified for their inclusion. In addition, the public health wheel is justified as a good reference frame along with value of information. Conclusion: We conclude that as the LAL model covers all dimensions and tools for translation and implementation in a defined method; it can therefore be considered as the overarching framework for translation and implementation into healthcare.

AB - Background: Recently, there has been a substantial increase in relevant genome-based technologies into market. Compared with its utilization in healthcare systems, we notice a huge gap. In order to address this bottleneck, we previously developed the Learning-Adapting-Leveling (LAL) model. Aim: In this article, we aim to demonstrate the overarching reach of the model for translation to market and implementation into healthcare systems moving towards personalized healthcare. Methods: We use qualitative logical reasoning with the LAL model as a reference. Results: We found that technology transfer, health needs assessment, health technology assessment and health impact assessment are justified for their inclusion. In addition, the public health wheel is justified as a good reference frame along with value of information. Conclusion: We conclude that as the LAL model covers all dimensions and tools for translation and implementation in a defined method; it can therefore be considered as the overarching framework for translation and implementation into healthcare.

UR - http://www.scopus.com/inward/record.url?scp=84893853118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893853118&partnerID=8YFLogxK

U2 - 10.2217/pme.13.97

DO - 10.2217/pme.13.97

M3 - Article

VL - 11

SP - 41

EP - 62

JO - Personalized Medicine

JF - Personalized Medicine

SN - 1741-0541

IS - 1

ER -